Overexpression of SphK1 offered protection to tumor tissues against anticancer drugs by shifting the ceramide/S1P balance towards the cytoprotective S1P [21]–[23] and also by the inhibition of cytochrome c release from mitochondria induced by chemotherapeutic agents [24]. The gene discussed is SPHK1; the disease is neoplasm.